A Certificate of Analysis COA is the primary document that verifies a peptide product's identity, purity, and potency through independent laboratory testing. This beginner's guide explains each COA component, how to interpret HPLC chromatograms and mass spectrometry results, what purity percentages…
Peptides are short chains of amino acids that are widely used in research settings and, in some cases, in clinical or compounded products. Because many peptide products are sold as research chemicals rather than regulated pharmaceuticals, buyers often rely on documentation rather than government oversight to assess quality. The Certificate of Analysis, commonly abbreviated as COA, is the most important document in that process. It is a laboratory report that claims to verify what is actually inside a vial, bag, or other container.
This guide explains what a COA should contain, how to interpret high-performance liquid chromatography HPLC and mass spectrometry results, what purity percentages mean in practice, and which warning signs should make a buyer question a product or supplier.
A Certificate of Analysis is an official document issued by a laboratory that has tested a product. In the peptide context, it confirms product composition, purity, identity, and potency through standardized testing methods. The COA provides objective, third-party verification of what is actually in the product versus what the label claims.
The word "independent" is central to the concept. The laboratory that issues the COA should have no financial or operational connection to the supplier. This separation is what makes the result impartial. When a supplier runs its own testing, the results are considered less reliable because the supplier has an incentive to produce favorable outcomes.
A complete COA should include several categories of information. Each one serves a different purpose, and a missing component can make the entire document significantly less useful.
The COA should state the peptide name, for example "Ipamorelin," and may also include the peptide sequence or molecular structure. It should list the lot number or batch number and the date the sample was analyzed. Together, these details confirm that the document refers to the specific product and batch you are considering, and not to a different product or an unrelated sample.
The date of testing matters because peptides are not indefinitely stable. Ideally, the test date should be within three to six months of your purchase. A test date older than one year is concerning, because the product may have degraded in storage, especially if it was not kept under appropriate conditions such as low temperature or away from moisture.
Purity percentage describes the portion of the product that is actually the intended peptide. The remaining percentage consists of impurities, excipients, or degradation products. Quality peptides typically show purity in the 90 to 98 percent range. A result below 90 percent suggests contamination or degradation and warrants caution.
Identity confirmation verifies that the sample is actually the peptide named on the label. This is usually done through methods such as HPLC or mass spectrometry. A trustworthy COA should explicitly state something like "peptide identity confirmed." If identity is not confirmed, the document is incomplete even if other numbers look acceptable.
For products sold as solutions or measured doses, the COA should state the actual peptide concentration, if applicable, and confirm that it matches the labeled concentration. A discrepancy between the measured concentration and the label suggests mislabeling or degradation. This check matters in research because dosing errors can make experimental results difficult or impossible to interpret.
The COA should list the analytical methods used, such as HPLC or mass spectrometry. Recognized, reliable methods matter because a purity number is only as meaningful as the technique that produced it. HPLC and mass spectrometry are widely considered the gold standards for peptide analysis.
A legitimate COA includes the laboratory name and contact information, the analyst's signature or credentials, and any license or accreditation information. These details should be independently verifiable, meaning you can contact the laboratory or confirm its accreditation through a public registry or other official channel.
The two most common analytical methods in peptide COAs are HPLC and mass spectrometry. Both generate graphical results, but they answer different questions. Understanding what each method shows is essential to reading a COA correctly.
HPLC, or high-performance liquid chromatography, separates the components of a sample and produces a chromatogram, which is a graph showing the different components detected. The main peak in the chromatogram represents the actual peptide. Peak height and peak area correspond to the amount of that component. Additional peaks represent impurities.
Purity is calculated from the relative areas of the peaks. A pure peptide sample shows one dominant peak with minimal other peaks. When reading an HPLC trace, look for a single large peak that accounts for 90 percent or more of the total area. If you see multiple significant peaks, that suggests contamination or the presence of related peptide fragments.
Mass spectrometry identifies the molecular weight and structure of compounds in a sample. The instrument measures the mass-to-charge ratio, abbreviated as m/z, and reports it as peaks on a spectrum. Each peptide has an expected molecular weight based on its amino acid sequence.
When reading a mass spectrometry result, look for a peak at the expected molecular weight of the peptide in question. The presence of that peak confirms that the actual peptide is present. A missing expected peak suggests the sample may contain the wrong peptide or be contaminated. Mass spectrometry can also identify specific impurities based on their characteristic masses.
Purity values give a quick sense of product quality, and the following ranges are commonly used as benchmarks:
It is important to note that lower purity does not necessarily mean the product is unsafe. It does, however, indicate that the quality is lower and that the product may contain more impurities, fragments, or degradation products than a higher-purity batch.
Several warning signs should make you treat a COA, or the supplier providing it, with caution. Recognizing these signs can prevent you from relying on documentation that does not actually support the product's quality.
A COA that lacks a purity percentage, a testing method, or a date is unreliable. Incomplete documentation should be a reason to avoid a supplier. A document with missing components cannot support the claims being made about the product.
Phrases like "general analysis" or unspecified methods suggest inadequate testing. Specific methods such as HPLC and mass spectrometry are preferable because they are measurable, reproducible, and verifiable.
Purity above 99.5 percent is theoretically possible, but such claims should be viewed with skepticism. Achieving ultra-high purity requires expensive, specialized processes that many suppliers do not have. A suspiciously high number may reflect exaggeration or fabrication rather than genuine quality.
Testing that is older than six to twelve months may not reflect the current quality of the product you are buying. Peptides can degrade over time, especially if stored improperly. Prefer COAs with recent test dates that align with the lot you are purchasing.
A COA should be specific to your lot number. Generic-looking documentation, such as a PDF that appears identical across different products or batches, suggests that actual testing may not have occurred. Each batch should have its own unique test results.
Legitimate laboratories clearly identify themselves. If a COA is missing the laboratory name, credentials, or contact information, the documentation is unreliable and should be questioned.
If the COA says one thing and the product labeling or supplier information says another, something is wrong. Consistency across all documentation is essential. Contradictions between the COA and other sources of information are a strong reason to avoid the product.
When evaluating multiple suppliers, the COA is a useful tool for side-by-side comparison. The goal is to determine whether quality differences are real and whether price differences are justified.
Labeled concentration refers to the stated amount of peptide per unit, for example the amount of peptide per vial or the amount per milliliter of solution. This figure should match the potency data reported in the COA. Comparing the actual measured concentration to the labeled concentration is a critical step because it can reveal mislabeling, dilution errors, or degradation. A product that falls short of its stated concentration may produce results that are difficult to interpret in any research context.
Many peptide products are sold for research purposes only and are not approved by regulatory agencies for human use. A Certificate of Analysis, even a complete and well-executed one, does not constitute regulatory approval or a guarantee of safety. Buyers should understand the legal and regulatory status of the products they purchase and should not interpret a COA as evidence that a product is approved for clinical or human use.